Correction to “Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro CYP Induction Studies Including Impact on Drug Interaction Risk Assessment”

doi:10.1124/dmd.120.000055err

Correction to “Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro CYP Induction Studies Including Impact on Drug Interaction Risk Assessment”

Drug Metabolism and Disposition ◽

10.1124/dmd.120.000055err ◽

2021 ◽

Vol 49 (4) ◽

pp. 344-344

Keyword(s):

Risk Assessment ◽

Drug Interaction ◽

Working Group ◽

Time Course ◽

Model Fitting ◽

Regulatory Agencies ◽

Cyp Induction ◽

Drug Drug Interaction

Download Full-text

Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro Cytochrome P450 Induction Studies Including Impact on Drug Interaction Risk Assessment

Drug Metabolism and Disposition ◽

10.1124/dmd.120.000055 ◽

2020 ◽

Vol 49 (1) ◽

pp. 94-110

Author(s):

Simon G. Wong ◽

Diane Ramsden ◽

Shannon Dallas ◽

Conrad Fung ◽

Heidi J. Einolf ◽

...

Keyword(s):

Risk Assessment ◽

Cytochrome P450 ◽

Drug Interaction ◽

Working Group ◽

Time Course ◽

Model Fitting ◽

Regulatory Agencies ◽

Cytochrome P450 Induction ◽

Drug Drug Interaction

Download Full-text

Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance

Drug Metabolism and Disposition ◽

10.1124/dmd.118.081927 ◽

2018 ◽

Vol 46 (9) ◽

pp. 1285-1303 ◽

Cited By ~ 8

Author(s):

Jane R. Kenny ◽

Diane Ramsden ◽

David B. Buckley ◽

Shannon Dallas ◽

Conrad Fung ◽

...

Keyword(s):

Drug Interaction ◽

Clinical Relevance ◽

Working Group ◽

Regulatory Agencies ◽

In Vitro Response ◽

Response Thresholds ◽

Drug Drug Interaction

Download Full-text

Evaluation of the time-course of CYP Induction and impact on drug interaction risk assessment from the IQ Induction working group

Drug Metabolism and Pharmacokinetics ◽

10.1016/j.dmpk.2018.09.146 ◽

2019 ◽

Vol 34 (1) ◽

pp. S40

Author(s):

Niresh Hariparsad ◽

Heidi Einolf ◽

David Buckley ◽

Shannon Dallas ◽

Josh Dekeyser ◽

...

Keyword(s):

Risk Assessment ◽

Drug Interaction ◽

Working Group ◽

Time Course ◽

Cyp Induction

Download Full-text

Recommendations for in vitro CYP3A4 mRNA data analysis for drug-drug interaction risk assessment from the IQ Induction working group

Drug Metabolism and Pharmacokinetics ◽

10.1016/j.dmpk.2018.09.159 ◽

2019 ◽

Vol 34 (1) ◽

pp. S44

Author(s):

Donald Tweedie ◽

Jane R. Kenny ◽

Diane Ramsden ◽

David Buckley ◽

Shannon Dallas ◽

...

Keyword(s):

Risk Assessment ◽

Drug Interaction ◽

Data Analysis ◽

Working Group ◽

Drug Drug Interaction

Download Full-text

Faculty Opinions recommendation of Variability in P-glycoprotein inhibitory potency (IC₅₀) using various in vitro experimental systems: implications for universal digoxin drug-drug interaction risk assessment decision criteria.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718043074.793480891 ◽

2013 ◽

Author(s):

Bruno Stieger

Keyword(s):

Risk Assessment ◽

Drug Interaction ◽

Decision Criteria ◽

Inhibitory Potency ◽

Experimental Systems ◽

P Glycoprotein ◽

Drug Drug Interaction

Download Full-text

Risk Assessment for Drug-Drug Interaction Caused by Metabolism-Based Inhibition of CYP3A Using Automated in Vitro Assay Systems and Its Application in the Early Drug Discovery Process

Drug Metabolism and Disposition ◽

10.1124/dmd.107.015016 ◽

2007 ◽

Vol 35 (7) ◽

pp. 1232-1238 ◽

Cited By ~ 44

Author(s):

Akiko Watanabe ◽

Koichi Nakamura ◽

Noriko Okudaira ◽

Osamu Okazaki ◽

Ken-ichi Sudo

Keyword(s):

Risk Assessment ◽

Drug Interaction ◽

Drug Discovery ◽

In Vitro Assay ◽

Discovery Process ◽

Drug Discovery Process ◽

Vitro Assay ◽

Drug Drug Interaction ◽

Early Drug

Download Full-text

Considerations from the IQ Induction working group in response to drug-drug interaction guidances from regulatory agencies

Drug Metabolism and Pharmacokinetics ◽

10.1016/j.dmpk.2018.09.055 ◽

2019 ◽

Vol 34 (1) ◽

pp. S11

Author(s):

Niresh Hariparsad

Keyword(s):

Drug Interaction ◽

Working Group ◽

Regulatory Agencies ◽

Drug Drug Interaction

Download Full-text

In vitro risk assessment of AZD9056 perpetrating a transporter-mediated drug–drug interaction with methotrexate

European Journal of Pharmaceutical Sciences ◽

10.1016/j.ejps.2011.03.006 ◽

2011 ◽

Vol 43 (1-2) ◽

pp. 41-49 ◽

Cited By ~ 22

Author(s):

Robert Elsby ◽

Lisa Fox ◽

David Stresser ◽

Mark Layton ◽

Caroline Butters ◽

...

Keyword(s):

Risk Assessment ◽

Drug Interaction ◽

Drug Drug Interaction

Download Full-text

Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control

Drug Metabolism and Disposition ◽

10.1124/dmd.116.074567 ◽

2017 ◽

Vol 45 (10) ◽

pp. 1049-1059 ◽

Cited By ~ 18

Author(s):

Niresh Hariparsad ◽

Diane Ramsden ◽

Jairam Palamanda ◽

Joshua G. Dekeyser ◽

Odette A. Fahmi ◽

...

Keyword(s):

Drug Interaction ◽

Working Group ◽

Positive Control ◽

Regulatory Agencies ◽

Drug Drug Interaction

Download Full-text

Variability in P-Glycoprotein Inhibitory Potency (IC50) Using Various in Vitro Experimental Systems: Implications for Universal Digoxin Drug-Drug Interaction Risk Assessment Decision Criteria

Drug Metabolism and Disposition ◽

10.1124/dmd.112.050500 ◽

2013 ◽

Vol 41 (7) ◽

pp. 1347-1366 ◽

Cited By ~ 98

Author(s):

Joe Bentz ◽

Michael P. O’Connor ◽

Dallas Bednarczyk ◽

JoAnn Coleman ◽

Caroline Lee ◽

...

Keyword(s):

Risk Assessment ◽

Drug Interaction ◽

Decision Criteria ◽

Inhibitory Potency ◽

Experimental Systems ◽

P Glycoprotein ◽

Drug Drug Interaction

Download Full-text